首页> 美国卫生研究院文献>Evidence-based Complementary and Alternative Medicine : eCAM >In Vitro Antiatherothrombotic Effects of Extracts from Berberis Vulgaris L. Teucrium Polium L. and Orthosiphon Stamineus Benth
【2h】

In Vitro Antiatherothrombotic Effects of Extracts from Berberis Vulgaris L. Teucrium Polium L. and Orthosiphon Stamineus Benth

机译:小BerTe粉和邻位菊苣的提取物的体外抗动脉粥样硬化作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Coronary artery disease is the leading cause of mortality and morbidity worldwide. The pathogenesis is mainly due to atherosclerosis, plaque rupture, and platelet thrombus formation. The main risk factors for coronary artery disease include obesity, hypercholesterolemia, smoking, diabetes, and high blood pressure. As a part of disease management, treatment options using anticoagulant and antiplatelet drugs can be applied with addition to lipid-lowering medication. However, medicinal plants comprising antiatherothrombotic effects can be used as options to combat the disease rather than drug therapies with lesser adverse effects. Therefore, the haematological effect of Berberis vulgaris L., Teucrium polium L., and Orthosiphon stamineus Benth extracts was studied using in vitro model to prevent and to treat coronary atherothrombotic disease. The aqueous, methanol, and polysaccharide extracts of B. vulgaris, T. polium, and O. stamineus, respectively, were studied for their anticoagulant and antiplatelet effect on human whole blood. Extracts were subjected to the prothrombin time (PT) and activated partial thromboplastin time (APTT) test for anticoagulant activity. The antiplatelet activity was investigated using an electrical impedance method. B. vulgaris aqueous extract (BVAE), B. vulgaris polysaccharide extract (BVPE), T. polium aqueous extract (TPAE), and T. polium polysaccharide extract (TPPE) significantly prolonged the coagulation time in a concentration-dependent manner (p<0.05). The administration of BVAE demonstrated the most effective antiplatelet activity against platelet aggregation caused by arachidonic acid (AA) and collagen. These antiplatelet activities may correspond to the presence of higher total phenolic compound, which thus inhibit the platelet aggregation activity. In conclusion, these findings provide strong evidence on the antiatherothrombotic effect of BVAE and TPAE.
机译:冠状动脉疾病是全球死亡率和发病率的主要原因。发病机理主要是由于动脉粥样硬化,斑块破裂和血小板血栓形成。冠状动脉疾病的主要危险因素包括肥胖,高胆固醇血症,吸烟,糖尿病和高血压。作为疾病管理的一部分,除降脂药物外,还可使用抗凝药和抗血小板药进行治疗。但是,具有抗动脉血栓形成作用的药用植物可以用作抗击该疾病的选择,而不是具有较小副作用的药物疗法。因此,使用预防和治疗冠状动脉粥样硬化性疾病的体外模型,研究了小Ber,Te和Te草提取物的血液学作用。研究了普通芽孢杆菌,T球菌和稻曲霉的水提取物,甲醇提取物和多糖提取物对人全血的抗凝作用和抗血小板作用。对提取物进行凝血酶原时间(PT)和活化部分凝血活酶时间(APTT)的抗凝血活性测试。使用电阻抗方法研究抗血小板活性。寻常B. 0.05)。 BVAE的给药对由花生四烯酸(AA)和胶原蛋白引起的血小板凝集显示出最有效的抗血小板活性。这些抗血小板活性可能对应于更高的总酚类化合物的存在,从而抑制了血小板聚集活性。总之,这些发现为BVAE和TPAE的抗动脉血栓形成作用提供了有力的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号